Basic information
Biomarker: β-catenin
Histology type: endometrial cancer
Cohort characteristics
Country: USA
Region: TX
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 190 | AH/EIN | 111 | normal controls | 79 |
Sample information
Conclusion: The results unequivocally demonstrate that some lesions that do not approach current histologic thresholds are bona fide neoplastic precursors with clinically-relevant driver events that can be detected by the 3-marker panel. The findings provide further validation for the diagnostic utility of the panel in clinical practice and its application in difficult or ambiguous cases.
Sample type : tissue
Sample method: immunocytochemistry
Disease information
Related information
Molecular function from UniProt:
